The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Diagnosis, treatment, and use of intravenous iron for chemotherapy-induced anemia in Europe.
M. S. Aapro
Consultant or Advisory Role - Vifor Pharma
Honoraria - Vifor Pharma
Y. Beguin
Consultant or Advisory Role - Vifor Pharma
Honoraria - Vifor Pharma
C. Bokemeyer
Consultant or Advisory Role - Vifor Pharma
Honoraria - Vifor Pharma
J. A. Glaspy
Consultant or Advisory Role - Vifor Pharma
Honoraria - Vifor Pharma
M. Hedenus
Consultant or Advisory Role - Vifor Pharma
Honoraria - Vifor Pharma
T. J. Littlewood
Consultant or Advisory Role - Vifor Pharma
Honoraria - Vifor Pharma
H. Ludwig
Consultant or Advisory Role - Vifor Pharma
Honoraria - Vifor Pharma
A. Osterborg
Consultant or Advisory Role - Vifor Pharma
Honoraria - Vifor Pharma
B. Rzychon
Employment or Leadership Position - Vifor Pharma
D. Mitchell
Employment or Leadership Position - Vifor Pharma